Evidence map›Paper›PMID 27869665›Full record

ReviewNutrients2016

Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols.

Jessy Moore, Michael Yousef, Evangelia Tsiani

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 280 citations in OpenAlex.

  1. Article
  2. Therapeutic Potential ofInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Toxicity and safety of rosemary (Rosmarinus officinalis): a comprehensive review.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Molecular Pathways of Genistein Activity in Breast Cancer Cells.International journal of molecular sciences · 2024
    Review

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jessy MooreDepartment of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada. jessy.moore@brocku.ca.
Michael YousefDepartment of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada. my11dq@brocku.ca.
Evangelia TsianiDepartment of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada. ltsiani@brocku.ca.
Brock University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer cells display enhanced growth rates and a resistance to apoptosis. The ability of cancer cells to evade homeostasis and proliferate uncontrollably while avoiding programmed cell death/apoptosis is acquired through mutations to key signaling molecules, which regulate pathways involved in cell proliferation and survival. Compounds of plant origin, including food components, have attracted scientific attention for use as agents for cancer prevention and treatment. The exploration into natural products offers great opportunity to evaluate new anticancer agents as well as understand novel and potentially relevant mechanisms of action. Rosemary extract has been reported to have antioxidant, anti-inflammatory, antidiabetic and anticancer properties. Rosemary extract contains many polyphenols with carnosic acid and rosmarinic acid found in highest concentrations. The present review summarizes the existing in vitro and in vivo studies focusing on the anticancer effects of rosemary extract and the rosemary extract polyphenols carnosic acid and rosmarinic acid, and their effects on key signaling molecules.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicCell Line, TumorCinnamatesDepsidesHumansNeoplasmsPhytotherapyPlant ExtractsPlants, MedicinalPolyphenolsRosmarinic AcidRosmarinusSignal TransductionXenograft Model Antitumor AssaysAntineoplastic Agents, PhytogenicCinnamatesDepsidesPlant ExtractsPolyphenolsRosmarinic Acidcancercarnosic acidcell signalingproliferationrosemary extractrosmarinic acidsurvival

Identifiers

PMID27869665
PMCPMC5133115
OpenAlexW2551193853

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.